For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Kazan' 4420029

0 studies enrolling now · 14 studies all time

What they study most

Acute Coronary Syndrome, Alzheimer's Disease, Autoimmune Disease, Connective Tissue Disease, Depressive Disorder, Major, Diabetes Mellitus, Type 2, Major Depressive Disorder, Psoriasis, Arthritic, Psoriatic Arthritis, Relapsing-Remitting Multiple Sclerosis, Rheumatoid Arthritis, Small Cell Lung Cancer

Studies at this site

• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• A Study of Ixekizumab in Participants With Active Psoriatic Arthritis — Completed
• A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Study in Participants With Rheumatoid Arthritis — Stopped early
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate — Stopped early
• A Study in Patients With Type 2 Diabetes Mellitus — Completed
• A Study in Adult Patients With Major Depressive Disorder — Completed
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder — Completed
• Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed
• Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) — Withdrawn before enrolling
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects — Completed
• Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer — Completed